Somatostatin Analogues in Pancreatic Neuroendocrine Tumors
0 Views
administrator
07/13/23
In this segment, Rodney Pommier, MD, and J. Philip Boudreaux, MD, review the role of somatostatin analogues and their adverse events in treating pancreatic neuroendocrine tumors.
-
Category
Show more
Facebook Comments
No comments found